These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16381420)

  • 41. Flexibility in community pharmacy: a qualitative study of business models and cognitive services.
    Feletto E; Wilson LK; Roberts AS; Benrimoj SI
    Pharm World Sci; 2010 Apr; 32(2):130-8. PubMed ID: 20016934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of perceived service quality and price competitiveness on consumer patronage of and intentions towards community pharmacies.
    Carter SR; Ahmed AM; Schneider CR
    Res Social Adm Pharm; 2023 May; 19(5):717-727. PubMed ID: 36806385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic dispensing in Egyptian community pharmacies: an observational study.
    Sabry NA; Farid SF; Dawoud DM
    Res Social Adm Pharm; 2014; 10(1):168-84. PubMed ID: 23665078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Care team perspectives on community pharmacy enhanced services.
    Fay AE; Ferreri SP; Shepherd G; Lundeen K; Tong GL; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2018; 58(4S):S83-S88.e3. PubMed ID: 30006190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Community pharmacy practice in Japan--results of a survey.
    Iguchi S; Ohnishi M; Nishiyama T; Hosono K; Umezawa C
    J Clin Pharm Ther; 1998 Jun; 23(3):223-7. PubMed ID: 9831974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dispensing errors and counseling quality in 100 pharmacies.
    Flynn EA; Barker KN; Berger BA; Lloyd KB; Brackett PD
    J Am Pharm Assoc (2003); 2009; 49(2):171-80. PubMed ID: 19289343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population characteristics associated with pharmacy-based influenza vaccination in United States survey data.
    Inguva S; Sautter JM; Chun GJ; Patterson BJ; McGhan WF
    J Am Pharm Assoc (2003); 2017; 57(6):654-660. PubMed ID: 28830660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacy specialists' attitudes toward pharmaceutical service quality at community pharmacies.
    Urbonas G; Jakušovaitė I; Savickas A
    Medicina (Kaunas); 2010; 46(10):686-92. PubMed ID: 21393987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
    Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
    J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring strategies to overcome extra-organisational challenges faced by community pharmacies in Sarawak, Malaysia.
    Kho BP; Hassali MA; Lim CJ; Saleem F
    Int J Pharm Pract; 2018 Dec; 26(6):494-500. PubMed ID: 29542834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Department of Veterans Affairs pharmacy services in 1992 and 1994 with strategic-planning goals.
    Portner TS; Srnka QM; Gourley DR; Hopkinson PL; Ogden JE; Muniz A; van Diepen LR
    Am J Health Syst Pharm; 1996 May; 53(9):1032-40. PubMed ID: 8744466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Community pharmacists' knowledge of and attitudes toward oral chemotherapy.
    O'Bryant CL; Crandell BC
    J Am Pharm Assoc (2003); 2008; 48(5):632-9. PubMed ID: 18826902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new model for pharmacies? Insights from a quantitative study regarding the public's perceptions.
    Policarpo V; Romano S; António JHC; Correia TS; Costa S
    BMC Health Serv Res; 2019 Mar; 19(1):186. PubMed ID: 30898124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the Pharmacy Safety Climate Questionnaire in European community pharmacies.
    Phipps DL; De Bie J; Herborg H; Guerreiro M; Eickhoff C; Fernandez-Llimos F; Bouvy ML; Rossing C; Mueller U; Ashcroft DM
    Int J Qual Health Care; 2012 Feb; 24(1):16-22. PubMed ID: 22140203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies.
    MacKeigan LD; Ijaz N; Bojarski EA; Dolovich L
    Res Social Adm Pharm; 2017; 13(5):947-958. PubMed ID: 28462792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How youth-friendly are pharmacies in New Zealand? Surveying aspects of accessibility and the pharmacy environment using a youth participatory approach.
    Horsfield E; Kelly F; Clark T; Sheridan J
    Res Social Adm Pharm; 2014; 10(3):529-38. PubMed ID: 23981912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness.
    Svarstad BL; Bultman DC; Mount JK
    J Am Pharm Assoc (2003); 2004; 44(1):22-9. PubMed ID: 14965149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Needs assessment study for community pharmacy travel medicine services.
    Hind CA; Bond CM; Lee AJ; van Teijlingen ER
    J Travel Med; 2008; 15(5):328-34. PubMed ID: 19006506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.